Avadel Pharmaceuticals (AVDL) Receivables - Net: 2009-2020
Historic Receivables - Net for Avadel Pharmaceuticals (AVDL) over the last 9 years, with Jun 2020 value amounting to $5.7 million.
- Avadel Pharmaceuticals' Receivables - Net fell 44.04% to $5.7 million in Q2 2020 from the same period last year, while for Jun 2020 it was $5.7 million, marking a year-over-year decrease of 44.04%. This contributed to the annual value of $8.3 million for FY2019, which is 26.91% down from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Receivables - Net of $5.7 million as of Q2 2020, which was down 35.30% from $8.8 million recorded in Q1 2020.
- In the past 5 years, Avadel Pharmaceuticals' Receivables - Net registered a high of $24.1 million during Q3 2017, and its lowest value of $4.9 million during Q1 2016.
- Its 3-year average for Receivables - Net is $10.6 million, with a median of $9.9 million in 2018.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Receivables - Net spiked by 176.73% in 2017, and later tumbled by 59.61% in 2018.
- Over the past 5 years, Avadel Pharmaceuticals' Receivables - Net (Quarterly) stood at $17.8 million in 2016, then decreased by 17.12% to $14.8 million in 2017, then declined by 23.37% to $11.3 million in 2018, then dropped by 26.91% to $8.3 million in 2019, then slumped by 44.04% to $5.7 million in 2020.
- Its Receivables - Net was $5.7 million in Q2 2020, compared to $8.8 million in Q1 2020 and $8.3 million in Q4 2019.